Agency of the United States Department of Health and Human Services
POPULARITY
Categories
In March 2022, Dr. Joseph Fraiman taped an internal call between FDA directors and physicians who were concerned about mRNA side effects in their patients – including the cardiac arrest and sudden death of a 7-year-old days after being injected with Pfizer's mRNA vaccine. “This was a top level meeting of directors,” Dr. Fraiman revealed to Ask Dr. Drew in Sept 2023. “This entire meeting terrified my entire work group.” The call – legally recorded by Dr. Fraiman – included FDA Director Dr. Peter Marks, Dr. Peter Doshi, Dr. Celia Witten, Dr. Sarah Walinsky, Dr. Lorrie McNeill, and many other experts. “What they're saying here is they're not doing statistical testing on adverse events. This is really insane to me,” Dr. Fraiman continued. “You know there's a problem if the vaccine group has a higher rate of them.” Dr. Joseph Fraiman, MD is an emergency physician and clinical researcher focused on harm-benefit analysis. He served as Medical Manager of Louisiana's Urban Search Rescue Disaster Task Force 1 and is lead author of a widely known re-analysis of mRNA vaccine serious harms. Follow at https://x.com/josephfraiman Dr. Stephanie Venn-Watson is Co-CEO and Co-Founder of Seraphina Therapeutics. She is a veterinary epidemiologist and author of “The Longevity Nutrient” (March 2025). Her background includes DARPA, the U.S. Navy Marine Mammal Program, and research on nutritional C15:0 deficiencies. Learn more at https://drdrew.com/fatty15 「 SUPPORT OUR SPONSORS 」 • AUGUSTA PRECIOUS METALS – Thousands of Americans are moving portions of their retirement into physical gold & silver. Learn more in this 3-minute report from our friends at Augusta Precious Metals: https://drdrew.com/gold or text DREW to 35052 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • VSHREDMD – Formulated by Dr. Drew: The Science of Cellular Health + World-Class Training Programs, Premium Content, and 1-1 Training with Certified V Shred Coaches! More at https://drdrew.com/vshredmd • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - https://kalebnation.com • Susan Pinsky - https://x.com/firstladyoflove Content Producer & Booking • Emily Barsh - https://x.com/emilytvproducer Hosted By • Dr. Drew Pinsky - https://x.com/drdrew Learn more about your ad choices. Visit megaphone.fm/adchoices
Jefferey unpacks a leaked FDA memo written by Dr. Vinay Prasad, head of the FDA's Center for Biologics and Research, which revealed at least 10 child deaths linked by internal analysts to the Covid vaccine, an admission the agency has never made publicly. He exposes how career scientists quietly raised alarms, how corporate media scrambled to distort the story, and why this marks a turning point in government transparency on vaccine safety.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
Episode 453: EXPOSING THE MOTIVEToday on The HighWire, Del reveals why the CDC quietly changed its vaccines-autism page — now stating the claim “vaccines do not cause autism” is not evidence-based. Jefferey Jaxen covers the FDA's bombshell disclosure that the COVID shot has killed at least 10 children, Europe's rejection of Bovaer cow feed, and why flaws in a new Cochrane HPV study undermine claims it prevents cervical cancer. Then, Carrie Bigford (Texans for Vaccine Choice) shares tools she developed to help advocates confidently navigate vaccine discussions. We'll check in live on the ACIP meeting, plus major news — ICAN will present to ACIP tomorrow at 9:30 AM ET. Del also sits down with Dr. Bob Sears to discuss MAHA leadership and the ACIP Hepatitis B vote. Guests: Carrie Bigford, Dr. Bob SearsBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
This interview took place on a historic day: the FDA removed the black box warning for HRT (hormone replacement therapy) after 20 years. My guest, Dr. Mariza Snyder, author of The Perimenopause Revolution, explains why this matters and why women have been suffering needlessly for decades while doctors dismissed their symptoms as "just aging" or "just stress." Perimenopause is the 4 to 10-year transition where hormones wildly fluctuate before menopause, and Dr. Snyder calls it "the window of vulnerability." She uses a powerful metaphor: imagine estrogen as your brain's master CEO who shows up like clockwork from 9 AM to 6 PM for 30 years. Then, suddenly, without warning, it shows up at 2 PM one day and leaves at 11 PM, then shows up at 6 AM the next day and leaves at 11 AM. Your brain scrambles trying to regulate energy, neurotransmitters, sleep, mood, and cravings. The most compelling insight of our conversation is a Mayo Clinic study that found 84% of menopausal women don't seek care. Why? Because they feel judged in the doctor's office. Dr. Snyder wrote her book as the roadmap she desperately needed when she started her own perimenopause journey, connecting symptoms to future health outcomes and providing practical solutions beyond just "you're getting older."
On this episode of Vitality Radio, Jared dives into why so many people are experiencing stubborn, lingering colds and sinus issues this season—and why the usual immune routines aren't cutting it. He breaks down the overlooked connections between the gut, liver, and immune system, and explains how supporting these systems can help the body return to normal, quicker recovery patterns. You'll also hear practical immune strategies for adults, kids, and pregnant/nursing moms, plus a few of Jared's favorite tools for respiratory support, sinus comfort, and overall immune resilience. And of course, Jared announces this year's Immune 25 Sale, with savings up to 25% on a collection of his top immune-supporting formulas. Whether you're trying to stay well or finally shake something that keeps coming back, this episode offers a clear path forward.Immune25 Sale through 1/31/26! BUILD YOUR OWN STACK FROM THE IMMUNE25 COLLECTION!2 different items - extra 10% off3 different items - extra 15% off4 or more items - extra 25% off *Please be sure to choose at least 3 different products!Additional Information:#590: Get Well and Stay Well This Cold and Flu Season. Plus a Fraud Alert!#413: Common Misconceptions About Colloidal Silver and the Power of Topical Silver Gel with Keith Moeller#367: Your Silver User's Guide: Colloidal, Ionic, Nano…What Does It All Mean, Is It Safe, And Does It Work?Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss the positive side effect of the shingles vaccine on dementia outcomes and how one dose of the HPV vaccine is non-inferior to two doses, but are dismayed about the FDA's secrecy around the inflammatory statement that the COVID-19 vaccine is linked to the death of 10 children. Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, effectiveness of maternal administration of the RVS vaccine or the COVID vaccine for neonates, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, how celiac plexus blocks improves gastrointestinal long COVID symptoms, brain alterations and neurodegenerative processes in long COVID cognitive impairment and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode The effect of shingles vaccination at different stages of the dementia disease course (Cell) FDA links 10 children's deaths to COVID-19 vaccines. Doctors want proof (ABC News) Subject: Deaths in children due to COVID-19 vaccines and CBER's path forward Dear Team CBER,(Washington Post) Noninferiority of One HPV Vaccine Dose to Two Doses(NEJM) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Washington state resident believed to be the first to die from a rare strain of bird flu (AP News) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) Types of Influenza Viruses (CDC: Influenza (flu)) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy (Obstetrics & Gynecology) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysis (CMI: Clinical Microbiology and Infection) SARS-CoV-2Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer (The Pediatric Infectious Disease Journal) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Case Report: Celiac plexus block improves gastrointestinal Long COVID symptoms (Frontiers Neuroscience) Distinct brain alterations and neurodegenerative processes in cognitive impairment associated with post-acute sequelae of COVID-19 (Nature Communications) Reaching out to US house representative Letters read on TWiV 1276 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.
What happens when the FDA quietly admits the thing they spent years censoring you for saying? This episode goes straight at the memo the media hoped you'd never see, the meltdown over SNAP work rules, why CNN is suddenly leaning on prediction markets, and the Christian symbolism hiding in plain sight inside Home Alone. Brian Nichols pulls all four threads together into one big story about trust, power, and what happens when the people in charge get caught rewriting reality. Studio Sponsor: Cardio Miracle - "Unlock the secret to a healthier heart, increased energy levels, and transform your cardiovascular fitness like never before.": CardioMiracle.com/TBNS Brian breaks down how institutions silenced dissent, crushed open debate, and are now acting shocked that America doesn't believe them anymore. From vaccines and government dependency to media spin and Christmas movies with surprising depth, this episode hits every beat: the tension, the culture, and the common sense the elites pretend they don't understand. If you want a commentary that cuts through the noise and actually respects your intelligence, this one's for you. ❤️ Order Cardio Miracle (CardioMiracle.com/TBNS) for 15% off and take a step towards better heart health and overall well-being!
Jordan Sather and Nate Prince spend this episode untangling a massive week of medical, regulatory, and food-system revelations, starting with the bombshell retraction of a decades-old glyphosate study after editors admitted Monsanto ghost-wrote it, undermining the scientific backbone of pesticide approvals. They move into the FDA's leaked internal memo linking COVID vaccines to at least ten child deaths, the media's frantic attempt to contain the story, and the unusual spectacle of former FDA commissioners rushing to publicly denounce their own agency. Jordan and Nate then cover RFK Jr.'s overhaul of vaccine advisory committees, the stunning vote to remove Hepatitis B from the childhood schedule, and the political fight exploding in Illinois as the state positions itself to override CDC guidance. From there, they dig into the USDA's crackdown on blue-state refusal to hand over SNAP-fraud data, revealing hundreds of thousands of dead or duplicate benefit recipients, and examine DOJ pressure on meat packers, raw-milk regulations, and the long-awaited PRIME Act. The episode wraps with conversations on DMSO, holistic health, doom-scrolling addiction, sardine challenges, and the push to reclaim nutrition, sovereignty, and sanity in a captured system.
In this episode, we break down the alleged NASA ISS broadcast failure that some viewers say happened just as a UAP crossed the screen. We also dive into surprising public statements from the head of the FDA involving ticks, Plum Island, and long-standing viral research rumors. To wrap it up, we explore the strange and captivating story of the Lady in Blue — a woman said to appear in two places at once. A mix of UAP talk, government mysteries, and supernatural history — all in one episode. Thanks to our sponsor, Uncommon Goods. Visit https://www.uncommongoods.com/ninjas for 15% off. #ad Get $10 Off at BRUNT with code NINJAS at https://www.bruntworkwear.com/NINJAS #Bruntpod #ad Exclusive $35 off Carver Mat with Promo Code NINJAS at https://on.auraframes.com/NINJAS #ad Get MORE Exclusive Ninjas Are Butterflies Content by joining our Patreon: https://www.patreon.com/NinjasAreButterflies NEW EPISODES EVERY FRIDAY @ 6AM EST! Ninja Merch: https://www.sundaycoolswag.com/ Start Your Custom Apparel Order Here: https://bit.ly/NinjasYT-SundayCool Learn more about your ad choices. Visit megaphone.fm/adchoices
PODCAST LAS NOTICIAS CON CALLE DE 5 DE DICIEMBRE 2025 - Vuelve el aumento de los peajes desde el contrato de Metropistas - Primera Hora Vuelven a pedir que el caso de Anthonieska se vaya a tribunal de menores, pospuesto el proceso otra vez - Primera Hora Hombre que cayó a La Plata murió, pero todavía no se sabe por qué - Primera Hora Le dieron 3 certificaciones a la secretaria de Educación Raíces para darle mejores sueldos - El Nuevo Día Todavía el gobierno de PR no tiene un jefe de PRITS de donde salen casi un billón de dólares en contratos indirectamente - El Vocero JGo se reúne con presidentes legislativos para trabajar en conjunto - El Nuevo Día Vivienda dice que va a acelerar el fin de los toldos azules - Metro Otro video de ataque de USA a lancha deja cuatro muertos - NYTPersonas anti vacunas se quedan con FDA y Sistema de Salud federal - Axios Netflix va a comprar HBO Max y sus estudios - Bloomberg Trump logra importante victoria en el Supremo, dejan a Texas montar su mapa para ganar el congreso republicano - FT Putin se reúne con jefe de India y le dice que le va a vender todo el combustible que quiera retando a Trump - CNBCCDevastadora decisión, Salud de PR decide dejar de cubrir medicamentos para rebajar - Cuarto Poder Para una salud completa, MCS Personal Directo te ofrece cubiertasaccesibles para que cuides de tu salud y la de los tuyos con el MCS Alivia, unprograma de medicina integral y alternativa que beneficia a pacientes con múltiplescondiciones crónicas, a través de terapias y servicios de acupuntura, masajeterapéutico, reflexología, entre otras modalidades, que pueden complementar tutratamiento médico tradicional.¡Únete HOY a la familia de MCS!¡Salud que completa tu vida! Llama al 787.945.1259 y oriéntate.Endoso pagado
This week on the New World Next Week: a new FDA memo confirms children died from the COVID vax; Campbell's VP lets slip that their soup is isht; and rage bait is the Oxford word(s) of the year!
NBA star Tim Hardaway sparked national outrage after saying “I hate gay people” on a Miami radio show in 2007. But his views shifted by 2013, when he was the first person to sign a petition for Florida's equal marriage amendment. Today, Hardaway Sr. says his earlier remarks were “truly wrong” and that guidance from family led him to rethink his views. In his new memoir “Killer Crossover” Hardaway reflects on being canceled (before “canceled” was a word), humbling himself, and how he returned to the spotlight: “the blood, sweat, and tears that went into becoming one of the most feared guards in the game and a future Hall of Famer.” Alex Berenson reports the FDA is considering a rare black box warning for Covid mRNA shots. TV producer Marcie Hume reveals what she learned after getting “unprecedented access” to Corey Feldman for her “Corey Feldman vs. the World” documentary, available for streaming on Dec 11. Alex Berenson is the author of Unreported Truths Substack and writes on public health, policy, and civil liberties. He is the New York Times bestselling author of multiple books. Follow him at https://x.com/AlexBerenson and read more at https://alexberenson.substack.com/ Tim Hardaway is a former NBA point guard known for the Killer Crossover and Run TMC. He is the author of Killer Crossover: My Life from the Chicago Streets to Basketball Royalty, available at https://amzn.to/4owgcr5. Find more at https://instagram.com/the_original_crossover_king Marcie Hume is a documentary filmmaker and producer of Corey Feldman vs. the World. She is VP at A&E Global Media and serves on the board of the Academy of Magical Arts. Follow at https://x.com/MarcieHume and watch the trailer online. 「 SUPPORT OUR SPONSORS 」 • AUGUSTA PRECIOUS METALS – Thousands of Americans are moving portions of their retirement into physical gold & silver. Learn more in this 3-minute report from our friends at Augusta Precious Metals: https://drdrew.com/gold or text DREW to 35052 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (https://kalebnation.com) and Susan Pinsky (https://twitter.com/firstladyoflove). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - https://kalebnation.com • Susan Pinsky - https://x.com/firstladyoflove Content Producer & Booking • Emily Barsh - https://x.com/emilytvproducer Hosted By • Dr. Drew Pinsky - https://x.com/drdrew Learn more about your ad choices. Visit megaphone.fm/adchoices
This week on the New World Next Week: a new FDA memo confirms children died from the COVID vax; Campbell's VP lets slip that their soup is isht; and rage bait is the Oxford word(s) of the year!
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big FDA recall around Freestyle Libre (see more below to find out if you're affected), Dexcom launches their 15.5 day sensor, Omnipod announces enhancements, Tandem tests a fully closed loop (with high fat, high carb meals) and lots more! Find out how to submit your Community Commercial Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. Our top story this week: XX Certain glucose monitors from Abbott Diabetes Care are providing users with incorrect glucose readings, an error that has been linked with the deaths of at least seven people and more than 700 serious injuries worldwide, according to an alert from the US Food and Drug Administration. Incorrect glucose readings can lead to improper treatment. Abbott warned that about 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors are affected, but no other Libre products. Patients can visit FreeStyleCheck.com to see if their sensors are affected and to get a replacement for free. The FDA has also published specific information about the affected products in its alert. The agency considers this to be a "potentially high-risk issue" and will continue to update its website as information becomes available. "Patients should verify if their sensors are impacted and immediately discontinue use and dispose of the affected sensor(s)," the FDA said. https://www.cnn.com/2025/12/02/health/abbott-diabetes-glucose-monitors https://www.freestylecheck.com/us-en/home.html XX Omnipod 5 is getting some enhancements.. and Omnipod 6 is announced. The FDA cleared updates including a lower, 100 mg/dL target glucose option and what they call a more seamless automated experience. "This is the most significant algorithm advancement to our Omnipod 5 System since its launch in 2022," said Eric Benjamin, Insulet EVP and COO. Insulet said the new 100 mg/dL target glucose expands Omnipod 5's customization range. It now features six settings between 100 mg/dL and 150 mg/dL in 10 mg/dL increments. The company said this flexibility allows healthcare providers to tailor insulin delivery more precisely. It supports individuals seeking tighter glucose management or aiming to meet specific glucose goals. Omnipod 5's latest upgrades also help users stay in "Automated Mode" with fewer interruptions, even during prolonged high glucose events. Insulet plans to launch the updates to the algorithm in the first half of 2026. The company announced plans for an Omnipod 6 – without a lot of detail - at the company's Investor Day event in November. They also talked about a new, fully closed-loop pump for the type 2 diabetes population. https://www.drugdeliverybusiness.com/insulet-fda-clearance-omnipod-5-algorithm-enhancements/ XX Dexcom, the global leader in glucose biosensing, announced today that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System will launch in the United States on Dec. 1, making it the longest-lasting CGM system with 15.5 days of wear. Dexcom G7 15 Day will first be available through durable medical equipment (DME) providers on Dec. 1 with full retail launch in the coming weeks. Dexcom G7 15 Day will also be covered for Medicare beneficiaries. Dexcom G7 15 Day's industry-leading wear-time will provide fewer sensor changes, less disruption and more time for people with diabetes to benefit from life-changing CGM technology. New with Dexcom G7 15 Day: Longest lasting CGM system with 15.5 days of wear. Best-in-class accuracy1 with an overall MARD of 8.0%. Easier glucose management with fewer monthly sensor changes and reduced monthly waste. This follows yesterday's announcement – the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults 18 and older with Type 2 diabetes using long-acting insulin. Dexcom Smart Basal will use Dexcom G7 15 Day sensor data and logged doses to calculate personalized daily recommendations to guide users towards a more effective long-acting insulin dose, as directed by their healthcare provider. At launch, Dexcom G7 15 Day will connect with the iLet Bionic Pancreas and Omnipod® 5§§. We are working closely with Tandem and look forward to extending the launch to their customers shortly as they finalize integration. For specific information on pump compatibility and availability with the Dexcom G7 15 Day system, visit Dexcom.com/connectedpumps https://investors.dexcom.com/news/news-details/2025/Dexcom-G7-15-Day-Continuous-Glucose-Monitoring-System-to-Launch-on-Dec--1-in-the-United-States/default.aspx XX A small study of ten adults with type 1 diabetes tested Tandem's new fully closed-loop "Freedom" insulin system — and the participants put it through a real-world stress test. For 72 hours in a hotel setting, they ate heavy carb-and-fat meals, skipped all meal announcements, and didn't give any mealtime insulin boluses. The system handled almost everything automatically. Researchers said the device stayed in closed-loop mode 97% of the time and there were no incidents of diabetic ketoacidosis or severe hypoglycemia reported. While using the Freedom system, participants spent a median 61% of the day in the glucose target range — slightly higher than the 56% achieved with their usual pump at home. But the biggest improvement came overnight: time in range jumped to 96% with the closed-loop system compared to just under 70% during their home-pump week. With almost zero time spent below 70 mg/dL, researchers concluded that the fully automated Tandem system was both safe and effective even with unannounced, high-impact meals — hinting at a future of diabetes management that demands less effort from users. XX Novo Nordisk reported promising mid-stage results for its experimental drug amycretin (AM-ee-creht-in) in diabetes patients on Tuesday. Amycretin, targets both GLP-1 and amylin hormones. In this study, it helped patients with type 2 diabetes lose up to 14.5% of their body weight over 36 weeks with weekly injections, far outperforming a placebo. The oral version delivered weight loss of up to 10.1%. Rival Eli Lilly is surging ahead with its own amylin-based drug, eloralintide, which is advancing to late-stage testing after helping patients shed as much as 20% of their weight in a mid-stage trial. https://www.cnbc.com/2025/11/25/novos-next-gen-obesity-drug-shows-positive-results-heads-to-late-stage-testing.html XX The U.S. Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those medications compared with recent annual spending, or about $8.5 billion in net covered prescription costs. The prices go into effect in 2027, including a monthly price of $274 for Novo Nordisk's popular GLP-1 drug semaglutide, sold as Wegovy for weight loss and Ozempic for diabetes. medicare's recent net price for Ozempic, opens new tab was $428 a month, according to an analysis published in the Journal of Managed Care and Specialty Pharmacy. Medicare put the drug's list price, before confidential rebates and discounts, at $959 a month. Based on such nondiscounted list prices, Medicare said savings on the 15 drugs ranged from 38% to 85%. The annual price negotiations were established under President Joe Biden's signature Inflation Reduction Act (IRA) of 2022. Previously, Medicare was barred by law from negotiating with drugmakers. https://www.reuters.com/business/healthcare-pharmaceuticals/us-negotiated-medicare-prices-15-more-drugs-test-cost-savings-promise-2025-11-25/ XX LifeScan announced its Chapter 11 bankruptcy reorganization plan received U.S. Bankruptcy Court approval. LifeScan said it's positioned to emerge from its financial restructuring process by the end of the year. The CEO says, "This balance sheet restructuring provides a stronger foundation for LifeScan to support our base business, advance new growth strategies, and commence our journey to become one of the most comprehensive players in the glucose management space." https://www.drugdeliverybusiness.com/glucose-monitor-lifescan-emerge-from-bankruptcy/ XX An artificial intelligence (AI)-led Diabetes Prevention Program (DPP) was as effective as a traditional human-led program in achieving recommended goals for weight loss, A1c reduction, and physical activity, according to a randomized trial of adults with prediabetes and overweight or obesity. One example of a push notification: "Looks like you're at the grocery store, Rita! Want a quick list of high-fiber snacks or smart swaps to stay on track this week?" The app also provided location- and goal-based education, with gamification elements to promote engagement. Approximately one third of participants in both the AI and human-led groups achieved the primary outcome (31.7% and 31.9%, respectively). Results were consistent across sensitivity analyses and individual components of the composite endpoint. "As more AI-based programs emerge, head-to-head comparisons among different AI-DPPs will be informative. An AI-led approach will not suit everyone; some individuals benefit more from human interaction and accountability," said Mathioudakis, adding that future research should focus on best matching patients to the modalities they prefer. https://www.medscape.com/viewarticle/ai-directed-diabetes-prevention-program-effective-human-2025a1000xam XX A new study suggets metformin could help people with type 1, reducing the need for insulin. The researchers were surprised to find that metformin did not improve insulin resistance or change blood sugar levels. This suggests that, unlike in type 2 diabetes, metformin doesn't combat insulin resistance in type 1 diabetes. However, metformin did reduce the amount of insulin people needed to keep their blood sugar levels stable. https://www.the-express.com/news/health/192157/diabetes-medicine-insulin-type-1 XX Beyond Type 1 launches #TheBeyondType campaign in India to combat type 1 diabetes stigma. Nick Jonas is one of the founders of Beyond Type 1, his wife, Priyanka Chopra Jonas is his partner in this new non profit. The initiative highlights inspiring individuals living with T1D and partners with local organisations to improve awareness, medical support, and community networks for affected families across the nation. India has more young people living with T1D than any other nation, yet understanding of the condition remains limited. Beyond Type 1 is partnering with grassroots organisations across high-need regions. These include HRIDAY in Delhi–NCR, Nityaasha Foundation in Pune, Gram Jyoti in Jharkhand, and SAMATVAM Trust in Bangalore—each group focusing on improving awareness, providing medical support and building stronger community networks for young people with T1D.
Were you told to "wait and see" after a DEXA bone screening or have you ever felt confused about what your T-score actually means, then this episode is for you? Today I am joined by two of the most respected bone health experts in the world, Dr. John Neustadt and Dr. Doug Lucas, to clear up the most misunderstood parts of bone loss in midlife. We cover How and why women in menopause should get bone density testing and how to actually understand what this means. Does estrogen really protect bones? Why are people having fractures despite good bone density scores without osteoporosis and vice versa. What are alternative screenings and how they compare to DEXA The downsides of bone screening and how to approach your bone health no matter if you have osteoporosis or not What the research supports for improving bone density and what supplements we may need to consider. We talk about the more important form of vitamin K and strontium What we need to know about that scary 30% of people die within a year of a hip fracture stat And so much more Dr. Doug Lucas I already mentioned that Dr. Doug Lucas is a leading expert in osteoporosis and longevity medicine. He really is. He is a double board-certified physician and founder of The OsteoCollective. This is an incredible community he has created where he helps people—especially midlife women—reverse bone loss, optimize hormones, and reclaim their strength and vitality through an evidence-based, root-cause approach. Dr. Doug is in the functional medicine space. And he has a special message for you: osteoporosis is not a life sentence, and conventional medicine isn't your only option. Remember that. Osteoporosis is not a life sentence, and conventional medicine isn't your only option. We've spoken in past episodes about how he left his career as an orthopedic surgeon after became so frustrated with a system that just waited until bones were broken before taking action. Now, he's on a mission to teach people how to take control of their health before disease sets in. He is such an incredible speaker and really delivers clear message that is relatable, and gives science-backed insights that we all can understand and act on. Dr. John Neustadt John Neustadt, ND, He is the Founder and President of the dietary supplement company Nutritional Biochemistry, Inc. (NBI, nbihealth.com) and NBI Pharmaceuticals. He received numerous US FDA Orphan Drug Designations for potentially treating rare diseases using natural products through his company. This means that the FDA gives the encourages him to continue to develop drugs and biologics that are intended to treat, diagnose, or prevent rare diseases or conditions. Dr. Neustadt hosts the Delivering Health podcast, which is also really great. He is also a Bone Health and Osteoporosis Foundation Corporate Advisory Roundtable member. And has written four books and over 100 research reviews. He was even recognized by Elsevier as a Top Ten Cited Author in the world for his work. This is huge. Check out his updated book, which you all get free access to in the show notes: Fracture-Proof Your Bones: A Comprehensive Guide to Osteoporosis. Contact Dr. Doug Lucas: Website: https://www.osteocollective.com/media Contact Dr. John Nuestadt Website: https://nbihealth.com/ Fracture-Proof Your Bones book www.nbihealth.com/osteobook Delivering Health Podcast www.nbihealth.com/podcast Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA here - http://oxfordhealthspan.com/discount/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try Suji to improve muscle 10% off with code ZORA at TrySuji.com - https://trysuji.com Try OneSkin skincare with code ZORA for 15% off https://oneskin.pxf.io/c/3974954/2885171/31050 Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: @Hack My Age Facebook Group: @Biohacking Menopause Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: @HackMyAge Website: HackMyAge.com For partnership inquiries: https://www.category3.ca/ Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.
In this episode of Healthy Mom Healthy Baby Tennessee, Dr. Linley Wolfe interviews Dr. Carrie Brackney, a maternal-fetal medicine physician in Memphis, about GLP-1 receptor agonist medications (commonly known as Ozempic, Wegovy, and similar drugs) and their implications for pregnancy. The discussion covers how these medications work, their dramatic effects on weight loss and diabetes management, and the emerging phenomenon of "Ozempic babies" - unintended pregnancies occurring in women taking these medications. Dr. Brackney provides guidance on when to discontinue these medications before conception, discusses limited safety data in pregnancy, and explains what monitoring is recommended for women who become pregnant while taking GLP-1s. Both physicians share their personal experiences with these medications and express hope for future research on postpartum use.Episode Highlights00:00:04: Welcome to Healthy Mom, Healthy Baby Tennessee podcast, brought to you by the Tennessee Initiative for Perinatal Quality Care (TIPQC), which exists to improve health outcomes for mothers and infants in Tennessee 00:00:46: Dr. Linley Wolfe introduces Dr. Carrie Brackney, a maternal-fetal medicine physician in Memphis who has been practicing as a perinatologist for three years after working as a general OB-GYN for nine years00:01:32: Dr. Brackney describes her passion for caring for women with complex pregnancies and helping them find joy during challenging times00:02:03: Dr. Wolfe introduces the topic of GLP-1 medications, noting they have been revolutionary for people struggling with weight00:02:38: Dr. Brackney explains that GLP-1 receptor agonists work by activating glucagon-like peptide one receptors, regulating blood sugar, reducing appetite, and slowing digestion through multiple mechanisms00:03:46: Discussion of how GLP-1 medications have been around for diabetes treatment but have been increasingly used for weight loss over the last four to five years00:04:04: Dr. Brackney notes these medications are also being used for patients with cardiovascular conditions and kidney disease, showing decreased complications00:04:28: Dr. Wolfe mentions recent approval for people who are overweight with sleep apnea, predicting more indications will emerge00:04:42: Cost identified as one of the biggest barriers to these medications becoming more popular00:05:01: Dr. Brackney reports that semaglutide and tirzepatide show potential for over 10% weight loss, while liraglutide shows 5-15% total weight loss00:05:49: Discussion of side effects, with nausea and constipation being the most common, though they are treatable and many people adjust over time00:06:09: Dr. Wolfe asks about common brand names versus generic names for listener clarity00:06:25: Dr. Brackney lists brand names including Ozempic, Wegovy, Rybelsus (semaglutide), Trulicity (dulaglutide), Victoza and Saxenda (liraglutide), and Mounjaro (tirzepatide)00:07:02: Discussion of compounded medications versus manufacturer medications, with Dr. Brackney noting compounded versions are not FDA-regulated and therefore not considered as safe00:07:55: Dr. Wolfe transitions to discussing pregnancy and the phenomenon of "Ozempic babies"00:08:51: Dr. Brackney explains that obesity reduces fertility, with obese women having three times higher risk of infertility and 40% higher miscarriage rates00:10:28: Discussion of how GLP-1 medications may interfere with contraceptive distribution in the body due to slowed gastric emptying00:11:04: Dr. Wolfe summarizes that better overall health, weight loss, and potential contraceptive interference all contribute to "Ozempic babies"00:11:27: Dr. Brackney recommends discontinuing GLP-1 medications at least one to two months before trying to get pregnant, noting limited data on ideal timing00:12:38: Discussion of the lack of...
Dr. Anthony Ferrari leads a team of scientists and researchers to develop innovative and effective CBD products. With over six years of experience in this role, he has successfully navigated the complex regulatory landscape of the CBD industry, ensuring compliance with FDA regulations and label requirements. Dr. Ferrari's expertise in analytical chemistry has enabled him to design and execute rigorous testing protocols, ensuring the quality and safety of the products his team produces. He is passionate about advancing the field of CBD research and education. He holds a PhD in Analytical Chemistry from Florida State University.
Listen to the SF Daily podcast for today, December 5, 2025, with host Lorrie Boyer. These quick and informative episodes cover the commodity markets, weather, and the big things happening in agriculture each morning. China's soybean purchases are lagging, with a reported 2.25 million metric tons, well below the 12 million target. Argentina's corn planting is 9% behind last year, raising concerns about late-season stress. USDA reported robust corn and wheat exports but a 39% drop in soybean exports. Cattle futures saw a positive week, with packers buying at higher prices. The FDA conditionally approved a topical solution for cattle. Winter weather advisories were issued for parts of the Midwest, with potential snowfall and slippery roads. Learn more about your ad choices. Visit podcastchoices.com/adchoices
You're listening to American Ground Radio with Stephen Parr and Louis R. Avallone. This is the full show for December 4, 2025. 0:30 Do you ever stop and think about what America used to be like? A country where political disagreements didn’t come packaged with threats, bankruptcies, mobs, and blacklists. From Reagan’s America to even Bill Clinton’s America, the conversation turns to how radically the tone has shifted under Obama and Biden. That sets the stage for the day’s story: Rep. Ilhan Omar launching a new boycott campaign — “We Ain’t Buying It” — aimed squarely at companies that work with the Trump administration. We unpack her loaded language: businesses must “pay a costly price” and she calls on supporters to use “every leverage” in their “arsenal.” We compare that rhetoric to historical patterns — from the French Revolution to Mao’s Red Guards to the Weather Underground — where phrases like “pay a heavy price” were precursors to coercion, destruction, and political violence. 9:30 Plus, we cover the Top 3 Things You Need to Know. More than four years after it happened, the FBI has finally made an arrest in the January 6th Pipe Bomb case. A new report out says there has been widespread fraud in Obamacare Subsidies. Two more Afghani immigrants to the US have been arrested on terrorism charges. 12:30 Get Prodovite Plus from Victory Nutrition International for 20% off. Go to vni.life/agr and use the promo code AGR20. 13:00 AT&T just joined the growing list of major corporations ditching their DEI programs — and we aren’t shedding a tear. We break down how deeply AT&T had plunged into the ideology, pushing training that claimed racism was a “uniquely white trait,” a stance that is not only absurd but openly discriminatory. From African ethnic conflicts to Imperial Japan’s belief in racial superiority, we point out the obvious: bigotry has never been exclusive to any one group. 16:00 The American Mamas dive into the big headline of the week: Michael and Susan Dell dropping a jaw-dropping $6.25 billion into Trump’s new children’s savings account program. Teri Netterville and Kimberly Burleson break down why this move could change the future for millions of kids, why early business education matters, and why generosity like this sparks both inspiration and outrage. If you'd like to ask our American Mamas a question, go to our website, AmericanGroundRadio.com/mamas and click on the Ask the Mamas button. 23:00 For the fourth month in a row, housing costs in America are falling — and the reason why has the left fuming. We break down how deporting two million illegal immigrants and ending mass releases at the border is reshaping the housing market. J.D. Vance calls the connection “clear as day,” and the numbers back him up. It’s simple economics, not politics — supply, demand, and what happens when you stop overwhelming the system. Common sense? Absolutely. Controversial? You bet. 25:00 The fatal flaw of socialism isn’t just that it has always failed — it’s that it can never succeed. We break down why “from each according to his ability, to each according to his need” works inside a loving family… but collapses the moment it’s applied to millions of imperfect human beings. Socialism demands angelic selflessness from everyone, all the time. Capitalism? It only requires people not to be outright monsters — a bar most folks can clear most of the time. From human nature to the Pilgrims to New Yorkers honking on the freeway, we dig deep into why socialism always slides into coercion, why capitalism aligns with reality, and why any system that relies on perfect people is doomed. 32:00 Get TrimROX from Victory Nutrition International for 20% off. Go to vni.life/agr and use the promo code AGR20. 32:30 We dive into a bombshell claim making waves: an internal FDA letter that critics say proves what they’ve been warning about for years — that young Americans were pushed into COVID shots they never needed, and that the government never wanted anyone questioning it. From vaccine mandates to college campuses, from “follow the science” to full-blown censorship, we walk back through how debate got shut down, how experts were elevated to unquestionable status, and how anyone who raised concerns — parents, doctors, journalists — was labeled a conspiracy theorist. 35:30 There’s finally a bright spot out of North Carolina this week—one that could change the game on violent repeat offenders. After months of shootings, releases, and a justice system that kept turning the same people back onto the streets, something different just happened in Charlotte. An 18-year-old—arrested multiple times for firing into homes—was picked up again. But this time? He didn’t walk free. His bond: $5.3 million. What changed? A brand-new law that just went into effect, born from a tragedy that never should have happened. And for the first time in a long time, it looks like consequences are finally catching up to the people who’ve been terrorizing innocent families. 40:00 And then there’s Mariah Carey—yes, the Christmas queen herself—making headlines again, but not for the song you’ve already heard 500 times this month. Over the summer, she showed up at an event in the U.K. wearing a glitter-bombed, rhinestone jacket that read “Protect the Dolls.” Now? She’s putting that jacket up for auction. And the cause it supports has a very specific mission: pushing more gender ideology into mainstream entertainment. So while everyone else is cueing up her Christmas tracks, she’s using her platform to bankroll something very different. And honestly… that deserves a big “whoa.” 41:30 And finally, a story that’ll restore a little of your faith in humanity. A first-year teacher in Virginia nearly lost her life after choking in front of her class—but three of her first graders jumped into action like seasoned pros. These kids didn’t panic—they became heroes. And their teacher says, “They 100% saved my life.” Now that’s the kind of story we need more of. Follow us: americangroundradio.com Facebook: facebook.com / AmericanGroundRadio Instagram: instagram.com/americangroundradioSee omnystudio.com/listener for privacy information.
Billy Gardell is an actor and stand-up comedian. He's currently on his Less Is More Tour with dates in Susanville, CA (Dec 6), Bellflower, CA (Dec 19), and Eau Claire, WI (Jan 30), with more info at billygardell.com. Follow him on X @billygardell and on Instagram @billygardellofficial.IN THE NEWS: The Trump administration freezes immigration applications from 19 countries, with officials hinting the blacklist could grow to more than 30 nations. The TSA piles on new travel headaches by announcing a $45 fee for passengers who show up to the airport without a REAL ID starting February 1. A top FDA official says an mRNA flu shot will not be approved after it failed to protect seniors in trials, raising fresh questions about next-gen vaccines. And in health and culture, male breast reduction surgery is now the most popular cosmetic procedure among American men, as more men seek treatment for gynecomastia and body-image concerns.Get it on.Subscribe to The Adam Carolla Show on Substack: https://adamcarolla.substack.com/FOR MORE WITH BILLY GARDELL:TOUR: Less is More TourDec 6 - Diamond Mountain Casino & Hotel - Susanville, CA Dec 19 - The Stand Up Comedy Club - Bellflower, CA Jan 30 - Pablo Center - Eau Claire, WI WEBSITE: Billygardell.comTWITTER: @billygardell INSTAGRAM: @billygardellofficial FOR MORE WITH RUDY PAVICH: INSTAGRAM: @rudy_pavichWEBSITE: www.rudypavichcomedy.comLIVE SHOWS: December 5 - Santa Barbara, CADecember 6 - Corona, CADecember 11 - Fort Lauderdale, FLDecember 12 - Miami, FL (2 Shows)December 13 - Miami, FL (2 Shows)December 14 - Fort Lauderdale, FLThank you for supporting our sponsors:CovePure.com/ADAMHims.com/ADAMForThePeople.com/Adamoreillyauto.com/ADAMPluto.tvRosettastone.com/ADAMRUGIET.com/ADAMSHOPIFY.COM/carollaNot only do you get 10% Off your entire order when you use code Adam at stopboxusa.com/Adam, but they are also giving you Buy One Get One Free for their StopBox Pro. #stopboxpod #adSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Immigration bills, FDA admission, possible new fed chairman, and honoring a D-Day veteran. Plus, the Message of the Day, Benjamin Franklin and fake news… Learn more about your ad choices. Visit megaphone.fm/adchoices
Today's show is WILD. Candace Owens vs TPUSA is spiraling, creators are predicting a full-on disaster, and Tim Pool says this could blow up the GOP.We also break down Frank Turek's rant, Trump roasting Ilhan Omar and calling out Mayor Frey, plus massive failures inside Social Security. Then — FDA “black box” warnings, Mike Lindell running for MN governor, Coleman Hughes explaining the Fuentes strategy, and Bella Hadid complaining about her privilege.SUPPORT OUR SPONSORS TO SUPPORT OUR SHOW!Whatever fall throws at you, make sure you're prepared—visit https://ReadyWise.com and use code CHICKS10 for 10% off your order today!Fill the nutrient gaps in your diet with Bioactive Multi from HealthyCell. Visit https://Healthycell.com/Chicks and use promo code CHICKS to save 20% on your first order.Save 15% off and stay seven times warmer this winter with Heat Holders at https://HeatHolders.com with code CHICKS—plus get free shipping on orders over $25!Nobody wants to deal with being sick during the holidays, get ready now with All Family Pharmacy. Use promo code CHICKS10 to save 10% off your order at https://AllFamilyPharmacy.com/ChicksSubscribe and stay tuned for new episodes every weekday!Follow us here for more daily clips, updates, and commentary:YoutubeFacebookInstagramTikTokXLocalsMore Info
Angel Studios https://Angel.com/HermanJoin the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability. Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here! Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeJenner Furst, director of the latest Angel Studios documentary "Thank You Dr. Fauci" joins the show.Episode Links:Thank You Dr. Fauci | Now Streaming | AngelBREAKING/URGENT: mRNA COVID VACCINES KILLED AT LEAST 10 KIDS, THE FDA REPORTS; An FDA review found the shots to blame for the deaths, FDA's new vaccine chief - Dr. Vinay Prasad - told staffers in an email. The agency will tighten standards on new vaccine approval, Prasad wrote.Fauci's Ebola stuntURGENT: mRNA Covid jabs should NEVER have been approved for children or young adults Pfizer, Moderna, the Biden Administration, and everyone in public health who pushed these for kids and teens have blood on their handsUnmask The Truth | Official Clip | Thank You, Dr. Fauci
Today's Headlines: The House Oversight Committee dropped another batch of photos and videos from Jeffrey Epstein's island, but honestly, this is not a “paint me a picture” situation — Google is your friend. Meanwhile, Pete Hegseth's Signalgate drama is heating up: an inspector general report says he put troops at risk, and Rep. Shri Thanedar is already drafting impeachment articles over both that and the whole “blow up random boats” era. Trump surprised literally everyone — including GOP leadership — by pardoning Democratic Rep. Henry Cuellar, who was awaiting trial for allegedly taking $600k in foreign bribes. And the administration announced a pause on immigration applications from 19 “high-risk” countries, with no timeline for resuming them, while a judge ruled that ICE actually does need warrants to arrest people in DC. Trump also claimed Jared Kushner and Steve Witkoff had a “very good” meeting with Putin on a Ukraine peace plan (sure), as European leaders slammed Putin for wasting everyone's time. And in a peak bit of irony, the former U.S. Institute of Peace has now been renamed the Donald J. Trump Institute of Peace.Finally, the FDA recalled more than 250,000 cases of shredded cheese sold nationwide due to possible metal contamination — a divine sign to stop buying store-brand cheese before it saws your intestines in half. Resources/Articles mentioned in this episode: CNN: New images and videos from Epstein's island released CNN: Watchdog finds Hegseth risked endangering troops by sharing of sensitive war plans on Signal, sources say Axios: Democrat announces articles of impeachment against Hegseth Axios: Scoop: Johnson blindsided by Trump's Cuellar pardon MS Now: Trump administration pauses immigration from 19 countries Axios: Federal judge restricts warrantless immigration arrests in D.C. Axios: Trump says Witkoff and Kushner had "a very good" meeting with Putin AP News: Europeans accuse Putin of feigning interest in peace after talks with US envoys Axios: Trump's name added to US Institute of Peace AP News: Shredded cheese sold in dozens of states recalled due to potential for metal fragment contamination Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices
Missed Rally Live #10? No worries! In this special episode, we're bringing you the powerful Rally Live #10 keynote from Sarah Herron—reality TV alum, writer, advocate, and founder of SheLift. While many of you first met Sarah on The Bachelor, her true impact has come from the way she's chosen to tell her own infertility story: with honesty, vulnerability, humor, and a fierce commitment to helping others feel less alone. In her keynote, Sarah opens up about living with a limb difference, navigating infertility, experiencing profound pregnancy loss, and redefining resilience on her own terms. She speaks candidly about grief, identity, mental health, and the unexpected places strength can be found. Her words remind us that we can hold joy and heartbreak at the same time—and that there is power in embracing our imperfections. She also talks about being a twin mom and a "Forever mom" to her sweet son, Oliver, who she honors every day. Follow Sarah on IG: @sarahherronEPISODE SPONSORS: THE WORK OF ART BOOK SERIESAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe latest book in the Work of ART series, “You Are a Work of ART," is for every kiddo born through ART -- and the people who love them.Order "Work of ART," "Beautiful Bird" and "You Are a Work of ART," now at https://www.infertileafgroup.com/booksFERTILITY RALLYIG: @fertilityrallywww.fertilityrally.comNo one should go through infertility alone. Join the Worst Club with the Best Members at fertilityrally.com. We offer 5 to 6 support groups per week, three private Facebook groups, tons of curated IRL and virtual events, and an entire community of more than 500 women available to support you, no matter where you are in your journey.Join today at link in bio on IG @fertilityrally or at www.fertilityrally.com/membershipPHERDALIG: @pherdal_sciencePherDal is the world's first and only FDA-cleared, sterile, at-home insemination kit designed to help people build their families in the comfort of home. Created by parents who've been there, PherDal is safe, simple, and affordable—putting more options in your hands as you grow your family. Explore at PherDal.com. Go to PherDal.com today and use code INFERTILEAF for $10 off. Support this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
We're continuing the Priestess Pilgrimage re-release series with one of my favorite conversations I've ever had — recorded in a tiny pink hotel room in Athens with my best friend, the brilliant and beloved Layla Martin. In Part 3, we travel through Crete, one of the last known matriarchal societies on Earth. Layla and I explore what happens when feminine spiritual authority isn't erased but honored — and how cultures change when women and men hold power side-by-side. We dive into the serpent priestesses of ancient Crete, the origins of Kundalini, the hidden role caves played in feminine rites, and what it means to turn up the dial on your own divinity in a grounded, embodied way. We also share the very human, very messy, hilariously sacred moments inside the cave ceremony — a reminder that sometimes the divine arrives with sweat, fear, laughter, and tourists stumbling through your initiation. If you've ever felt the pull toward ancient feminine wisdom or sensed there's more to your own divinity than you've been taught… this episode is a homecoming. In this episode, we explore: • Ancient Crete & what true feminine leadership looked like • Why high priestesses held political, spiritual, and cultural authority • The serpent priestesses & how Kundalini was encoded in art • How caves became temples for birth, fertility, sexuality & magic • Using psychedelics intentionally to awaken—not escape • Preparing your body and nervous system for spiritual expansion • The real, messy moments behind mystical experiences Key Moments: [00:01:13] Returning from Crete & why this leg of the pilgrimage mattered [00:03:59] The soul memory that called Emily & Layla to Crete [00:04:47] Gnosis: the ancient queendom run by priestesses [00:07:21] Minoan matriarchy & serpent priestess symbolism [00:22:39] Entering the cave — the womb of the earth [00:28:11] Sacred sexuality & psychedelics as pathways to the divine [00:30:27] The cave initiation: fear, clearing & cosmic humor [00:36:03] Preparing your body for spiritual expansion [00:52:21] Mystical states without substances [01:00:08] Meditation as the foundation for integration About Layla Martin: Founder of the VITA Method, Tantra teacher, and internationally respected guide in sexual, emotional, and spiritual awakening. Instagram: @thelaylamartin • laylamartin.com ✨ Join the Upcoming Pilgrimage to Greece — Spring 2026 If this conversation stirs something ancient in you… listen to it. A refundable deposit secures your spot to apply for Emily's next Greece Mastermind + Pilgrimage. Learn More: zivameditation.com/pages/nextlevel MORE FROM EMILY & ZIVA: Join Ziva Magic: zivameditation.com/pages/zivamagic Learn Ziva Meditation: preview.zivameditation.com Free masterclass: learn.zivameditation.com Get 15% off with promo code WHYTHIS: whythis.zivameditation.com Follow us on Instagram: @zivameditation Visit upgradedformulas.com/emily and use code EMILY for 20% off everything at UpgradedFormulas.com These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider if pregnant/nursing, on medication, or have a medical condition.
Plus: A group of former FDA commissioners has criticized the agency's new vaccine standards, citing risks to public health. And UBS says the world has more billionaires than ever. Daniel Bach hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
Six years ago we had John Newman on GeriPal to talk about Geroscience (Song choice Who Wants to Live Forever by Queen, perfect selection). John explained the basics of geroscience, what is it, what are the key theories in geroscience, what is senescence, why people who provide clinical care for older adults should care about geroscience, and potential therapeutics like metformin and rapamycin. Today we bring on three rising stars in Geroscience, Brian Andonian, Sara LaHue, Joe Hippensteel, to talk about one of the key pillars of Geroscience: inflammaging. We use this terrific paper they published in Geroscience as a springboard. We discuss: What is inflammaging? Chronic progressive low grade inflammation with aging. I try to get one of them to stake a claim that inflammaging should be the organizing principle of geroscience How does inflammaging operate in rheumatologic conditions like rheumatoid arthritis (Brian), neurologic conditions like traumatic brain injury (Sara), and critical illness (Joe). We talk about Post-ICU Syndrome (PICS) and relate inflammaging to our prior podcast with Wes Ely about his book Every Deep Drawn Breath. We also talk about how inflammaging is not just a factor in chronic conditions like diabetes or inflammatory bowel disease, which make intuitive sense, but also in acute conditions, like sepsis or traumatic brain injury in older adults. The state of the science on clinical and research tests for inflammaging - ready for prime time? What is the state of the science for therapeutics? Why should some anti-inflammatory therapeutics make us nervous in frail older adults? Inflammation developed evolutionarily for a reason. E.g. tthink of drugs that wipe out the immune system. The outsized discrepancy between non-FDA products marketed to consumers as anti-inflammaging and the state of academic Geroscience. We announce GeriPal's new lineup of skin care anti-inflammaging products! We discuss lifestyle interventions such as exercise, meditation, caloric restriction and intermittent fasting, and strength/resistance training. We recognize the efforts of ClinStar in bringing together multidisciplinary aging researchers to advance aging research, including our guests. And what a joy to sing Billy Joel! Here's a link to the documentary I mentioned, which is on my list to see. -Alex Smith
In this episode, Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda, joined us to discuss the FDA approval process for pioneer and generic animal drugs. She also discussed veterinary devices, pharmacy compounding, counterfeit drugs, and more. This episode of Disease Du Jour is brought to you by Bimeda.GUESTS AND LINKS - EPISODE 171Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)Guest: Stephanie Batliner, VP of Regulatory Affairs and R&D North America for BimedaPodcast Website: Disease Du JourThis episode of Disease Du Jour podcast is brought to you by Bimeda.Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)
“This is a time to reimagine public health and public health/healthcare system integration,” says Dr. Deb Houry, the former chief medical officer for the US Centers for Disease Control and Prevention. In this thoughtful Raise the Line conversation, Dr. Houry reflects on unprecedented federal action in vaccine guidance and other issues since her noteworthy resignation from the CDC in August, and sees a more decentralized landscape emerging where states and localities play a larger role in providing public health recommendations. And while she acknowledges upsides to this shift, she's also concerned what the absence of a national consensus on health standards could mean. “Diseases don't recognize borders, and it's also important that people have equitable access to preventative services, vaccines, and other things,” she tells host Lindsey Smith. Tune in for Dr. Houry's seasoned perspective on this consequential moment in public health, and her encouraging message for learners and early career providers considering a career in the sector.Mentioned in this episode:DH Leadership & Strategy Solutions If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
On this week's episode of the Glossy Beauty Podcast, we're exploring what teens are hoping to receive for the holidays. To do so, Sara Spruch-Feiner speaks to 13-year-old Indy (whose last name is omitted for privacy), based in Los Angeles, who shares her full wishlist with us, as well as the picks of members of her volleyball team. But to get a broader look at the gifting landscape in 2025, Spruch-Feiner also interviewed Anna Andreeva, managing director of footwear, beauty and brands at Piper Sandler. Piper Sandler, a financial services company, is well-known for its biannual teen survey, which, this fall, tapped 11,000 teens, most of whom were 15-18 years old and had an average household income of about $70,000. But first, a look at some of this week's headlines, including results of this year's Black Friday and Cyber Monday spending, the FDA's decision to withdraw a proposed rule that would have required beauty brands to test talc-based cosmetics for asbestos contamination, and, finally, the news that LVMH Ventures Fund has invested in the niche perfume brand BDK Parfums.
Welcome to the Oncology Brothers podcast! In this episode, we dived into the complexities of non-malignant hematology, focusing on iron abnormalities—both deficiency and overload. We welcomed Dr. Marina Beltrami from The Ohio State University, who guided us through three challenging clinical scenarios: 1. Anemia in Pregnancy: We discussed a 34-year-old woman in her second trimester with low MCV and ferritin levels, exploring treatment options including the safety and efficacy of IV iron versus oral iron. 2. Anemia with Mixed Etiologies: We analyzed a case involving a 78-year-old man with a history of prostate cancer, diabetes, and chronic kidney disease, discussing the broad differential diagnosis and the role of bone marrow biopsy and molecular studies. 3. Iron Overload: We examined a 47-year-old woman with elevated ferritin levels and a heterozygous hemochromatosis mutation, debating the necessity of phlebotomy and the importance of liver imaging. Throughout the episode, we emphasized the significance of a comprehensive iron panel and the clinical context in diagnosing and managing these conditions. Dr. Beltrami shared valuable insights on the use of erythropoietin-stimulating agents in chronic kidney disease and the potential risks associated with their use. Tune in for an informative discussion packed with practical insights for healthcare professionals dealing with iron-related disorders! Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Don't forget to like, subscribe, and check out our other episodes for more discussions on treatment algorithms, conference highlights, and FDA approvals. We are the Oncology Brothers! #Anemia #IronDeficiency #Hemochromatosis #IronOverload #Hematology #Ferritin #OncologyBrothers
▶︎▶︎Preorder my new book ‘The Connection Code': https://beehive.drmelissasonners.com/the-connection-code If you're in your 40s and have been feeling “off” lately: low energy, anxious for no clear reason, gaining weight around your middle, waking up at 3AM, or wondering why your sex drive suddenly disappeared — there's a powerful explanation hiding in your hormones. These symptoms are some of the most common early perimenopause signs, even in women who still have regular periods.In this episode, I sit down with women's hormone & menopause expert Dr. Mariza Snyder to break down the ONE midlife hormone shift that can silently disrupt your mood, metabolism, sleep, libido, stress tolerance, and sense of self. This neuroendocrine transition often starts in your late 30s or 40s, and understanding it is the key to feeling like yourself again.We talk about the hidden hormone changes most women don't realize they're experiencing, why so many women in midlife describe feeling “lost,” and what's actually driving symptoms like anxiety, brain fog, irritability, weight changes, low motivation, and emotional overwhelm.This season of life is an incredible opportunity to rebirth your energy, clarity, and purpose.What You'll Learn:The midlife hormone imbalance that affects mood, sleep, weight, and libidoEarly perimenopause symptoms women often missWhy so many women in their 40s feel disconnected or “not like themselves”The brain chemistry changes behind anxiety, irritability, and overwhelmThe identity “upgrade” that happens during hormonal shiftsExercise snacks for blood sugar, metabolism, and emotional regulationPleasure stacking & nervous system tools for daily stressLow libido in perimenopause — what's hormonal vs emotionalThe newest HRT research + FDA vaginal estrogen updateHow to rebuild community and connection during life transitionsResources:Dr. Mariza Snyder: https://drmariza.com/ Get her book ‘The Perimenopause Revolution: Reclaim Your Hormones, Metabolism & Energy': https://amzn.to/3FwSAlK Melissa's Red Light faves, with special codes and discounts: https://www.drmelissasonners.com/red-light-guide Be Inspired Mama Journal: https://amzn.to/4afbs3s Want a free and meaningful way to support the show? Give us a ⭐️⭐️⭐️⭐️⭐️ rating on Spotify or Apple Podcasts (you can even leave a review on Apple too!). And if you're tuning in on YouTube, don't forget to like, comment, and subscribe. Your support helps more mamas discover this space and we're so grateful you're here.
Dr. Roger McFillin was interviewed by Renaud Beauchard from Tocsin Media—France's leading independent media platform with 30 million monthly views. In this unflinching conversation, Dr. Roger McFillin exposes what he calls a deliberate psychological operation on the American people: a system designed not to heal but to create lifelong customers, sever your connection to God, and make you dependent on medical authority for problems that were never diseases in the first place. The chemical imbalance theory? Born in pharmaceutical marketing rooms, not laboratories. ADHD? A label that stops investigation into the real causes poisoning our children. This isn't incompetence. It's an attack on human consciousness itself. And the first step to freedom is understanding exactly how they did it to you. Visit Center for Integrated Behavioral HealthDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here
Send us a textThe FDA recently issued a public warning about the risks of radiofrequency microneedling, citing burns, scarring, fat loss, and nerve damage. Headlines blew up, social media panicked, and patients are left wondering: Is RF microneedling actually dangerous?In this episode of The Trillium Show, board-certified plastic surgeon Dr. Jason Hall breaks down the new FDA advisory in plain language. He explains what sparked the warning, what risks are legitimate, and what the FDA statement really means for patients and providers.Dr. Hall covers:- Why RF microneedling is considered a medical procedure, not a cosmetic service- The complications the FDA highlighted and how often they actually happen- Why experience, training, and device selection matter more than ever- The difference between superficial treatments that build collagen and deeper devices that can destroy fat- How informed consent and appropriate expectations minimize risk- The “cowboy problem” with aggressive settings and one-and-done promisesIf you're considering RF microneedling (or offering it), this episode is essential listening.
Howie and Harlan are joined by Sudhakar Nuti to discuss his work improving healthcare for homeless New Yorkers, as a street-medicine doctor and a population-health leader at NYC Health + Hospitals. Harlan reports on a proposed law that would cut off funding for U.S. scientists who collaborate with colleagues in China; Howie provides updates on the measles outbreak and a leaked FDA memo claiming that COVID-19 vaccines have killed 10 children. Show notes: Science Across Borders Subtitle C—SAFE Research Act "U.S. Congress considers sweeping ban on Chinese collaborations" Sudhakar Nuti NYC Health + Hospitals Street Medicine Institute "Health Care beyond Clinic Walls—Sustaining and Scaling Up Street Medicine" NYC Health + Hospitals: Street Health Outreach & Wellness Mobile Units "Graduate and professional students tackle food insecurity" California Depart of Public Health: Xylazine Measles CDC: Measles Cases and Outbreaks "Tracking U.S. Measles Outbreaks" World Health Organization: Weekly Epidemiological Record, 2025, vol. 100, no. 48 "Winning against measles: five charts that tell a remarkable 24-year story" "Measles deaths down 88% since 2000, but cases surge" FDA Leak "Experts say top FDA official's claim that Covid vaccines caused kids' deaths requires more evidence" "FDA's Prasad tells staffers agency plans to get tougher on vaccine regulation, blames child deaths on COVID shots" "Thoughts on Vinay Prasad's Leaked Email" "Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021" "Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.
Dr. Monty Pal and Dr. Jason Westin discuss the federal funding climate for cancer research and the persistent problem of drug shortages, two of the major concerns facing the oncology community in 2026. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcast. I am your host, Dr. Monty Pal. I am a medical oncologist and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles. There are always multiple challenges facing oncologists, and today, we discuss two of them that really stand out for 2026: threats to federal funding for cancer research and the persistent problem of drug shortages. I am thrilled to welcome Dr. Jason Westin, who believes that one way to meet these challenges is to get oncologists more involved in advocacy, and he will share some strategies to help us meet this moment in oncology. Dr. Westin is a professor in the Department of Lymphoma and Myeloma at the University of Texas MD Anderson Cancer Center, but he actually wears a lot of hats within ASCO. He is a member of the Board of Directors and has also previously served as chair of ASCO's Government Relations Committee. And he is also one of the inaugural members of ASCO's Political Action Committee, or PAC. He has testified before Congress about drug shortages and many other issues. Dr. Westin, I am really excited to have you on the podcast today and dive into some of these elements that will really impact our community in 2026. Thanks so much for joining us today. Dr. Jason Westin: Thank you for having me. Dr. Monty Pal: You've had such a range of experience. I already alluded to you testifying before Congress. You've actually run for office before. You wear so many different hats. I'm used to checking my PubMed every other day and seeing a new paper out from you and your group, and you publish in the New England Journal [of Medicine] on practice-setting standards and the diseases that you treat. But you've also done all this work in the domain of advocacy. I can't imagine that balancing that is easy. What has sort of motivated you on the advocacy front? Dr. Jason Westin: Advocacy to me is another way to apply our skills and help more people than just those that you're sitting across from at the time. Clinical research, of course, is a tool to try and take what we know and apply it more broadly to people that you'll never meet. And advocacy, I think, can do the same thing, where you can have a conversation with a lawmaker, you can advocate for a position, and that hopefully will help thousands or maybe even more people down the road who you'd never get to directly interact with. And so, I think it's a force multiplier in the same way that research can be. And so, I think advocacy is a wonderful part of how doctors care for our patients. And it's something that is often difficult to know where to start, but once people get into advocacy, they can see that the power, the rewarding nature of it is attractive, and most people, once they get going, continue with that through the rest of their career. Dr. Monty Pal: So, I'll ask you to expand on that a little bit. We have a lot of our younger ASCO members listening to this podcast, folks that are just starting out their careers in clinical practice or academia. Where does that journey begin? How do you get to the point that you're testifying in front of Congress and taking on these bigger sort of stances for the oncology community? Dr. Jason Westin: Yeah, with anything in medicine and in our careers, you have to start somewhere. And often you start with baby steps before you get in front of a panel of senators or other high-profile engagement opportunities. But often the first setting for junior colleagues to be engaged is doing things – we call them "Hill Days" – but basically being involved in kind of low-stakes meetings where you're with a group of peers, some of whom have done this multiple times before, and can get engaged talking to members of representatives' offices, and doing so in a way where it's a natural conversation that you're telling a story about a patient in your clinic, or that you're telling a personal experience from a policy that impacted your ability to deliver optimal care. It sounds stressful, but once you're doing it, it's not stressful. It's actually kind of fun. And it's a way that you can get comfort and skill with a group of peers who are there and able to help you. And ASCO has a number of ways to do that, both at the federal level, there's the Hill Day where we each April have several hundred ASCO members travel to Capitol Hill. There's also state engagement that can be done, so-called visiting at home, when representatives from the U.S. Congress or from state legislators are back in district. You can meet with your own representatives on behalf of yourself, on behalf of your organization, and advocate for policies in a way that can be beneficial to your patients. But those initial meetings that are in the office often they're low stakes because you could be meeting not with the representative but with their staff. And that staff sometimes is as young or even younger than our junior colleagues. These sometimes can be people in their 20s, but they're often extremely knowledgeable, extremely approachable, and are used to dealing with people who are new to advocacy. But they actually help make decisions within the office. So it's not a waste of time. It's actually a super useful way to engage. So, it's that first step of anything in life. The activation energy is always high to do something new. But I'd encourage people who are listening to this podcast already having some level of interest about it to explore ways that they could engage more. Dr. Monty Pal: You know, I have to tell you, I'm going to riff on what you just said for a second. ASCO couldn't make it any easier, I think, for folks to participate and get involved. So, if you're listening to this and scratching your head and thinking, "Well, where do I begin? How do I actually sign on for that meeting with a local representative?" Go to the ASCO ACT Network website. And I'll actually talk to our producer, Geraldine, to make sure we've got a link to that somewhere associated with this podcast after it's published, Jason, but I actually keep that on my browser and it's super easy. I check in there every now and then and see if there's any new policy or legislation that ASCO, you know, is sort of taking a stance on, and it gives me some fodder for conversation with my local representatives too. I mean, it's just an awesome, awesome vehicle. I'm going to segue right from there right to the issues. So, you and I are both at academic centers. You know, I think this is something that really pervades academia and enters into implications for general clinical practice. There's been this, you know, massive sort of proposal for decreased funding to the NCI and to the NIH and so forth. Tell us what ASCO is doing in that regard, and tell us perhaps how our community can help. Dr. Jason Westin: We live in interesting times, and I think that may be an understatement x 100. But obviously investments in research are things that when you're at an academic center, you see and feel that as part of your daily life. Members of Congress need to be reminded of that because there's a lot of other competing interests out there besides investing in the future through research. And being an elected representative is a hard job. That is something where you have to make difficult choices to support this, and that may mean not supporting that. And there's lots of good things where our tax dollars could be spent. And so, I'm sympathetic to the idea that there's not unlimited resources. However, ASCO has done an excellent job, and ASCO members have led the charge on this, of stating what research does, what is the benefit of research, and therefore why should this matter to elected representatives, to their staff, and to those people that they're elected to serve. And ASCO has led with a targeted campaign to basically have that message be conveyed at every opportunity to elected representatives. And each year on Hill Day, one of the asks that we have is to continue to support research: the NCI, NIH, ARPA-H, these are things that are always in the asks to make sure that there's appropriate funding. But effectively playing offense by saying, "It's not just a number on a sheet of paper, this is what it means to patients. This is what it means to potentially your loved ones in the future if you are in the opposite situation where you're not on the legislative side, but you're in the office receiving a diagnosis or receiving a difficult piece of news." We only have the tools we have now because of research, and each breakthrough has been years in the making and countless hours spent funded through the engine of innovation: clinical research and translational research. And so ASCO continues to beat that drum. You mentioned earlier the ACT Network. Just to bring that back again is a very useful, very easy tool to communicate to your elected representatives. When you sign up on the ASCO ACT website, you get emails periodically, not too much, but periodically get emails of, "This is a way you can engage with your lawmakers to speak up for this." And as you said, Monty, they make it as easy as possible. You click the button, you type in your address so that it figures out who your elected representatives are, and then it will send a letter on your behalf after like five clicks to say, "I want you to support research. I want you to vote for this particular thing which is of interest to ASCO and by definition to members of ASCO." And so the ACT Network is a way that people listening can engage without having to spend hours and significant time, but just a few clicks can send that letter to a representative in Congress. And the question could be: does that matter? Does contacting your senator or your elected representative do anything? If all they're hearing is somebody else making a different argument and they're hearing over and over again from people that want investments in AI or investments in something else besides cancer research, whatever it is, they may think that there's a ground shift that people want dollars to be spent over here as opposed to at the NIH or NCI or in federally funded research. It is important to continue to express the need for federal funding for our research. And so, it really is important for folks to engage. Dr. Monty Pal: 100%. One of the things that I think is not often obvious to a lot of our listeners is where the support for clinical trials comes from. You know, you've obviously run the whole gamut of studies as have I. You know, we have our pharmaceutical company-sponsored studies, which are in a particular bucket. But I would say that there's a very important and critical subset of studies that are actually government funded, right? NCI-funded clinical trials. If you don't mind, just explain to our audience the critical nature of the work that's being done in those types of studies and if you can, maybe compare and contrast the studies that are done in that bucket versus perhaps the pharmaceutical bucket. Dr. Jason Westin: Both are critical, and we're privileged that we have pharma studies that are sponsored and federally funded clinical research. And I think that part of a healthy ecosystem for us to develop new breakthroughs has a need for both. The pharma sponsored studies are done through the lens of trying to get an approval for an agent that's of interest so that the pharma company can then turn around and use that outside of a clinical trial after an FDA approval. And so those studies are often done through the lens of getting over the finish line by showing some superiority over an existing treatment or in a new patient population. But they're done through that lens of kind of the broadest population and sometimes relatively narrow endpoints, but to get the approval so that then the drug can be widely utilized. Clinical trials done through cooperative groups are sometimes done to try and optimize that or to try and look at comparative things that may not be as attractive to pharma studies, not necessarily going for that initial approval, but the fine tuning or the looking at health outcomes or looking at ensuring that we do studies in representative populations that may not be as well identified on the pharma sponsored trials, but basically filling out the gaps in the knowledge that we didn't gain from the initial phase 3 trial that led to the approval. And so both are critical. But if we only do pharma sponsored trials, if we don't fund federally supported research and that dries up, the fear I have, and many others have, is that we're going to be lacking a lot of knowledge about the best ways to use these great new therapies, these new immune therapies, or in my team, we do a lot of clinical trials on CAR T-cell therapies. If we don't have federally funded research to do the important clinical studies, we'll be in the dark about the best ways to use these drugs, and that's going to be a terrible shame. And so we really do need to continue to support federal research. Dr. Monty Pal: Yeah, there are no softball questions on this podcast, but I think everybody would be hard pressed to think that you and I would come on here and say, "Well, no, we don't need as much money for clinical trials and NCI funding" and so forth. But I think a really challenging issue to tackle, and this is something we thought to ask you ahead of the podcast, is what to do about the general climate of, you know, whether it's academic research or clinical practice here that seems to be getting some of our colleagues thinking about moving elsewhere. I've actually talked to a couple of folks who are picking up and moving to Europe for a variety of considerations, other continents, frankly. The U.S. has always been a leader when it comes to oncology research and, one might argue, research in general. Some have the mindset these days that we're losing that footing a little bit. What's your perspective? Are you concerned about some of the trends that you're seeing? What does your crystal ball tell you? Dr. Jason Westin: I am highly concerned about this. I think as you said, the U.S. has been a leader for a long time, but it wasn't always. This is not something that's preordained that the world-leading clinical research and translational research will always be done in the United States. That is something that has been developed as an ecosystem, as an engine for innovation and for job development, new technology development, since World War II. That's something that through intentional investments in research was developed that the best and brightest around the world, if they could choose to go anywhere, you wanted them to come to work at universities and academic places within the United States. And I think, as you said, that's at risk if you begin to dry up the investment in research or if you begin to have less focus on being engaged in research in a way that is forward thinking, not just kind of maintaining what we do now or only looking at having private, for profit sponsored research. But if you don't have the investment in the basic science research and the translational research and the forward-thinking part of it, the fear is that we lose the advantage and that other countries will say, "Thank you very much," and be happy to invest in ways to their advantage. And I think as you mentioned, there are people that are beginning to look elsewhere. I don't think that it's likely that a significant population of researchers in the U.S. who are established and have careers and families – I don't think that we're going to see a mass exodus of folks. I think the real risk to me is that the younger, up-and-coming people in undergraduate or in graduate school or in medical school and are the future superstars, that they could either choose to go into a different field, so they decide not to go into what could be the latest breakthroughs for cancer patients but could be doing something in AI or something in a different field that could be attractive to them because of less uncertainty about funding streams, or they could take that job offer if it's in a different country. And I think that's the concern is it may not be a 2026 problem, but it could be a 2036 or a 2046 problem that we reap what we sow if we don't invest in the future. Dr. Monty Pal: Indeed, indeed. You know, I've had the pleasure of reviewing abstracts for some of our big international meetings, as I'm sure you've done in the past too. I see this trend where, as before, we would see the preponderance of large phase 3 clinical trials and practice setting studies being done here in the U.S., I'm seeing this emergence of China, of other countries outside of the U.S. really taking lead on these things. And it certainly concerns me. If I had to sort of gauge this particular issue, it's at the top of my list in terms of what I'm concerned about. But I also wanted to ask you, Jason, in terms of the issues that are looming over oncology from an advocacy perspective, what else really sort of keeps you up at night? Dr. Jason Westin: I'm quite concerned about the drug shortages. I think that's something that is a surprisingly evergreen problem. This is something that is on its face illogical that we're talking about the greatest engine for research in the world being the United States and the investment that we've made in drug development and the breakthroughs that have happened for patients all around the world, many of them happen in the United States, and yet we don't necessarily have access to drugs from the 1970s or 1980s that are cheap, generic, sterile, injectable drugs. This is the cisplatins and the vincristines and the fludarabine type medications which are not the sexy ones that you see the ads in the magazine or on TV at night. These are the backbone drugs for many of our curative intent regimens for pediatrics and for heme malignancies and many solid tumors. And the fact that that's continuing to be an issue is, in my opinion, a failure to address the root causes, and those are going to require legislative solutions. The root causes here are basically a race to the bottom where the economics to invest in quality manufacturing really haven't been prioritized. And so it's a race to the cheapest price, which often means you undercut your competitor, and when you don't have the money to invest in good manufacturing processes, the factory breaks down, there's no alternative, you go into shortage. And this has been going on for a couple of decades, and I don't think there's an end in sight until we get a serious solution proposed by our elected officials. That is something that bothers me in the ways where we know what we should be doing for our patients, but if we don't have the drugs, we're left to be creative in ways we shouldn't have to do to figure out a plan B when we've got curative intent therapies. And I think that's a real shame. There's obviously a lot of other things that are concerning related to oncology, but something that I have personally had experience with when I wanted to give a patient a CAR T-cell, and we don't have a supply of fludarabine, which is a trivial drug from decades ago in terms of the technology investments in genetically modified T-cells, to not then have access to a drug that should be pennies on the dollar and available at any time you want it is almost like the Air Force investing in building the latest stealth bomber, but then forgetting to get the jet fuel in a way that they can't use it because they don't have the tools that they need. And so I think that's something that we do need to have comprehensive solutions from our elected officials. Dr. Monty Pal: Brilliantly stated. I like that analogy a lot. Let's get into the weeds for a second. What would that proposal to Congress look like? What are we trying to put in front of them to help alleviate the drug shortages? Dr. Jason Westin: We could spend a couple hours, and I know podcasts usually are not set up to do that. And so I won't go through every part. I will direct you that there have been a couple of recent publications from ASCO specifically detailing solutions, and there was a recent white paper from the Senate Finance Committee that went through some legislative solutions being explored. So Dr. Gralow, ASCO CMO, and I recently had a publication in JCO OP detailing some solutions, more in that white paper from the Senate Finance. And then there's a working group actually going through ASCO's Health Policy Committee putting together a more detailed proposal that will be published probably around the end of 2026. Very briefly, what needs to happen is for government contracts for purchasing these drugs, there needs to be an outlay for quality, meaning that if you have a manufacturing facility that is able to deliver product on time, reliably, you get a bonus in terms of your contract. And that changes the model to prioritize the quality component of manufacturing. Without that, there's no reason to invest in maintaining your machine or upgrading the technology you have in your manufacturing plant. And so you have bottlenecks emerge because these drugs are cheap, and there's not a profit margin. So you get one factory that makes this key drug, and if that factory hasn't had an upgrade in their machines in 20 years, and that machine conks out and it takes 6 months to repair or replacement, that is an opportunity for that drug to go into shortage and causes a mad dash for big hospitals to purchase the drug that's available, leaving disparities to get amplified. It's a nightmare when those things happen, and they happen all the time. There are usually dozens, if not hundreds, of drugs in shortage at any given time. And this has been going on for decades. This is something that we do need large, system-wide fixes and that investment in quality, I think, will be a key part. Dr. Monty Pal: Yeah, brilliantly said. And I'll make sure that we actually include those articles on the tagline for this podcast as well. I'll talk to our producer about that as well. I'm really glad you mentioned the time in your last comment there because I felt like we just started, but in fact, I think we're right at our close here, Jason, unfortunately. So, I could have gone on for a couple more hours with you. I really want to thank you for these absolutely terrific insights and thank you for all your advocacy on behalf of ASCO and oncologists at large. Dr. Jason Westin: Thank you so much for having me. I have enjoyed it. Dr. Monty Pal: Thanks a lot. And many thanks to our listeners too. You can find more information about ASCO's advocacy agenda and activities at asco.org. Finally, if you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Thanks so much. ASCO Advocacy Resources: Get involved in ASCO's Advocacy efforts: ASCO Advocacy Toolkit Crisis of Cancer Drug Shortages: Understanding the Causes and Proposing Sustainable Solutions, JCO Oncology Practice Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers: Dr. Monty Pal @montypal Dr. Jason Westin @DrJasonWestin Follow ASCO on social media: @ASCO on X ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Monty Pal: Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis Dr. Jason Westin: Consulting or Advisory Role: Novartis, Kite/Gilead, Janssen Scientific Affairs, ADC Therapeutics, Bristol-Myers Squibb/Celgene/Juno, AstraZeneca, Genentech/Roche, Abbvie, MorphoSys/Incyte, Seattle Genetics, Abbvie, Chugai Pharma, Regeneron, Nurix, Genmab, Allogene Therapeutics, Lyell Immunopharma Research Funding: Janssen, Novartis, Bristol-Myers Squibb, AstraZeneca, MorphoSys/Incyte, Genentech/Roche, Allogene Therapeutics
In one of our most eye-opening conversations yet, Bo Brabo and Luke Carignan sit down with clinical pharmacist Langley Kyle to unpack the truth behind GLP-1 medications—Wegovy, Ozempic, Zepbound, tirzepatide, and their compounded counterparts. Whether you're an HR leader, benefits strategist, or simply trying to understand why GLP-1s dominate workplace conversations, this episode breaks it all down with clarity, expertise, and a surprising amount of laughter.From skyrocketing utilization to social-media-driven demand, Langley reveals what she's seeing across employer plans nationwide…and what's coming next.
On this episode of Dr. Osborne's Zone, we're focusing on empowering individuals with autoimmune diseases, such as rheumatoid arthritis, Hashimoto's, Multiple Sclerosis, lupus, and more to take control of their health through actionable steps. The conventional medical system often fails to address the root causes of autoimmune conditions, which are often linked to nutrient deficiencies, microbial imbalances, as well as chemical and emotional stressors. We need an "autoimmune revolution" - a holistic approach that includes proper nutrition, gut health, and understanding the triggers of autoimmunity. I cannot overstate the importance of nutrient-dense foods and the detrimental effects of processed diets on immune function. In this video, I aim to educate viewers on how to improve their health by addressing deficiencies and restoring gut integrity, ultimately leading to better management of autoimmune diseases.Gluten Sensitive? Take the quiz & Join Our Community ▶https://www.glutenfreesociety.org/gluten-sensitivity-intolerance-self-test/Get my quick start guide on going gluten free: https://www.glutenfreesociety.org/how-to-go-gluten-free/Nutritional Crash Courses Playlist: https://www.glutenfreesociety.org/nutritionGet Gluten Free Supplements: https://www.glutenfreesociety.org/shop-home/No Grain No Pain the Book: https://www.glutenfreesociety.org/NoGrainNoPainGlutenology Masterclass (Ultimate Guide): https://glutenology.net/registrationTo connect with Dr. Osborne visit:On the web: https://drpeterosborne.com/Facebook: https://www.facebook.com/DoctorPeterOsborne/TikTok: https://www.tiktok.com/@drpeterosborneInstagram: https://www.instagram.com/drosborneTwitter: https://twitter.com/glutenologyPinterest: https://www.pinterest.com/docosborne/Podcast:Apple Podcasts: https://podcasts.apple.com/us/podcast/dr-osbornes-zone/id1706389688?uo=4Spotify: https://open.spotify.com/show/4Zdf07GgpRAVwlSsYvirXTAmazon Music/Audible: https://music.amazon.com/podcasts/20d71b2e-3554-4569-9d5b-4259785cdc94Google Podcasts: https://www.google.com/podcasts?feed=aHR0cHM6Ly93d3cuc3ByZWFrZXIuY29tL3Nob3cvNTkwNjcwNC9lcGlzb2Rlcy9mZWVkiHeart Radio: https://iheart.com/podcast/119388846Dr. Peter Osborne is one of the most sought after alternative and nutritional experts in the world. A Diplomate with the American Clinical Board of Nutrition, a graduate of Texas Chiropractic College, and a doctor of pastoral science, Dr. Osborne is one of the world's leading authorities on gluten, nutrition, and natural health. He is the founder GlutenFreeSociety.org, one of the world's largest informational sites on gluten sensitivity. In addition, he is the author of the best selling book, No Grain No Pain, published by Touchstone (Simon & Schuster). His work has been featured by PBS, Netflix, Amazon, Fox, U.S. News, Ney York Post, and many other nationally recognized outlets.For collaborations please email: glutenology@gmail.comAny information on diseases, treatments, nutrition, or other health related topics from this channel are for educational purposes only, and should not be considered a substitute for advice provided by your doctor or healthcare provider. Bottom line...if you have health issues, you should always seek professional medical guidance.Products and supplements discussed in this video have not been evaluated by the FDA. They are not intended to treat, cure, or diagnose. Dr. Osborne is an Amazon affiliate, and many earn from qualifying purchases. For more information, visit us at https://www.glutenfreesociety.org/ or call 281-903-7527
Episode 2731 - Vinnie Tortorich and Chris Shaffer discuss the evolution of beliefs, what we tell ourselves, junk food trends, and more. https://vinnietortorich.com/2025/12/what-we-tell-ourselves-episode-2731 PLEASE SUPPORT OUR SPONSORS Pure Vitamin Club Pure Coffee Club NSNG® Foods VILLA CAPPELLI EAT HAPPY KITCHEN YOU CAN WATCH THIS EPISODE ON YOUTUBE - @FitnessConfidential Podcast What We Tell Ourselves Note: There is a discussion around Santa and beliefs—if you have little ones around while listening, we encourage listener discretion. The origin of the "Daisy Dukes" and the show Dukes of Hazard. (3:00) They discuss how information about topics like climate change has changed, and that we are always learning. Vinnie relates the belief in Santa to the belief in what is possible. (13:00) We tell ourselves things we want to be true, so we can get what we want. (16:30) Oral semiglutide's effects are supposed to be as effective as the injection, but there are still side effects. (21:00) "The Decaf study." They discuss decaf and caffeinated coffee and whether it is harmful enough. Taco Bell has its own soda flavor, Baja Blast. (28:00) They just launched their own pie based on the same flavor. People think they can get away with one thing if they believe they are compensating elsewhere, but that doesn't always work that way. CICO, or taking a GLP-1, is an example of this; people will indulge, thinking that the running or the GLP-1 will take care of the fallout. (36:00) The FDA is lifting black box warnings from women's estrodiol packaging. (51:00) This allows women options that they didn't think were possible before to treat perimenopause and menopausal symptoms. Our Sponsor Jaspr Air Scrubbers has a discount code, VINNIE, that gets you $400 off through Black Friday. Jaspr offers a lifetime warranty. Go to Jaspr.co for more information or to purchase. Don't forget to sign up for the NSNG VIP group. Vinnie's video workouts will be free to all members! (1:05:00) You can get on the wait list -https://vinnietortorich.com/vip/ Also, you'll want to join as soon as it opens, because once it closes again, it will be closed indefinitely. You can book a consultation with Vinnie to get guidance on your goals. https://vinnietortorich.com/phone-consultation-2/ More News Serena has added some of her clothing suggestions and beauty product suggestions to Vinnie's Amazon Recommended Products link. Self Care, Beauty, and Grooming Products that Actually Work! Don't forget to check out Serena Scott Thomas on Days of Our Lives on the Peacock channel. "Dirty Keto" is available on Amazon! You can purchase or rent it here.https://amzn.to/4d9agj1 Please make sure to watch, rate, and review it! Eat Happy Italian, Anna's next cookbook, is available! You can go to https://eathappyitalian.com You can order it from Vinnie's Book Club. https://amzn.to/3ucIXm Anna's recipes are in her cookbooks, website, and Substack — they will spice up your day! https://annavocino.substack.com/ Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine. Details are at Eat Happy Kitchen. https://eathappykitchen.com/ PURCHASE DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views it receives, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries
In our news wrap Wednesday, Israel received remains believed to be those of one of the last two hostages still in Gaza, President Trump proposed rolling back fuel efficiency standards set by the Biden administration and a dozen former FDA commissioners say they're "deeply concerned" about proposed changes that would create a far stricter process for vaccine approvals. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy
FDA admits the C19 'VACCINE' killed children, viral door kicking challenge, sex offender walks into a school with nobody aware, Target creeps out customers with new policy, shivering burns fat and a clever idea used in Oklahoma to feed people and reduce court fines! Direct all hate mail to voicesofmiserypodcast@gmail.com Twitter: @voicesofmisery mewe: @voicesofmisery Parler: voices of misery Gmail: voicesofmiserypodcast@gmail.com Instagram: voicesofmiserypodcast Discord server: voices of misery podcast https://tinyurl.com/VoMPodcastTees
America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – The latest leaked FDA letter, there looks to be a chance for radical changes inside the 'public health' deep state. Last week a letter written several months ago from the director of the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad MD MPH, was leaked - and it was scintillating. Several key acknowledgments...
Nationally recognized psychiatrist, internist, and addiction medicine specialist Muhamad Aly Rifai discusses his article, "The rise of digital therapeutics in medicine." Muhamad explains what prescription digital therapeutics (PDTs) are, emphasizing they are not wellness apps but Food and Drug Administration (FDA)-cleared, evidence-based software prescribed by clinicians to treat specific diagnoses. He explores the groundbreaking examples already authorized by the FDA, including software for substance use disorder, a video game for pediatric attention-deficit/hyperactivity disorder (ADHD), and a new adjunct treatment for major depressive disorder. Muhamad breaks down how these digital therapeutics are designed to work alongside (not replace) human clinicians, offering continuous, skill-building support for mental health conditions. Learn how this new category of medicine is moving care from the exam room into the patient's daily life and what it means for the future of treatment. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended
This episode of Vitality Radio is a rerun of a conversation that's perfect for this time of year with holiday gatherings and extra treats! When it comes to healthy eating, what if it's not about perfection, but empowerment? How can we balance health and indulgence? On this episode, Jared welcomes Jenn Trepeck, host of the Salad with a Side of Fries podcast, for refreshingly honest conversation about making sustainable health choices—without the pressure of perfection. They discuss how understanding the why behind our choices creates true transformation, why willpower isn't what we think it is, and how to approach real-life situations like vacations, barbecues, and late-night cravings with balance. You'll learn actionable mindset shifts that support long-term wellness, without guilt or rigidity. Jared and Jenn explore the emotional and behavioral side of nutrition, helping you align your choices with your goals—while still enjoying the occasional treat.Buy Vital Kids Multi OR Vital C Immunity and receive Clinical Immunity Elderberry Gummies FREE - Vitality Radio POW! Product of the Week with PROMO CODE: POW19Additional Information:Salad with a Side of Fries - websiteSalad with a Side of Fries - podcastJenn Trepeck - InstagramVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
The Revolutionary Role of the Vagus Nerve in Bioelectronic Medicine: Dr. Kevin J. Tracey, president and CEO at the Feinstein Institutes for Medical Research and author of "The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes,” details the historical context and recent advancements in harnessing the power of the vagus nerve to control inflammation without causing immunosuppression. The conversation explores the journey from early experimental stages to the recent FDA approval for treating rheumatoid arthritis through vagus nerve stimulation (VNS) devices. He also delves into the potential applications of VNS in treating other inflammatory conditions, mood disorders, and the science behind non-invasive lifestyle techniques and commercially available devices. The episode provides valuable insights into the future of bioelectronic medicine and its potential to revolutionize medical treatments.
Jackie has changed her Yelping ways and writes not one, but two powerful, glowing reviews for a local oyster bar, reviews Wicked for Good, and goes cold turkey on Diet Coke in preparation for Paris.Thanks for supporting my sponsors:Revolve: Shop my favorites, and use code BITCH to get 15% off your first order at www.Revolve.com/BITCHBetterHelp: Get 10% off your first month at www.BetterHelp.com/BITCHBIBLEPique: Unlock 20% off for life for yourself and everyone on your list at www.Piquelife.com/BibleLittle Spoon: Use code BIBLE to get 50% off your first online order at www.littlespoon.com/BIBLEAddyi: Check out the FDA-approved treatment for certain premenopausal women who are bothered by low libido and want their sex drive back at www.Addyi.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In Part 1 of her story (I Sold My Body to Save My Horse) Nikki turned to the oldest profession in a desperate bid to survive. Now she searches for stability while facing new crises that imperil not only herself but her horse. DRIP DROP Get 20% off your first order: dripdrop.com and use promo code secret. HERS Visit forhers.com/SECRET for your personalized weight loss treatment options. Hers Weight Loss by Hers is not available everywhere. Compounded products are not approved or reviewed for safety, effectiveness, or quality by the FDA. Prescription required. See website for full details, important safety information, and restrictions. Actual price depends on product and plan purchased. HOME CHEF For a limited time, get 50% off and free shipping for your first box PLUS free dessert for life! HomeChef.com/SECRET. Must be an active subscriber to receive free dessert. PICTURES See pictures of Nikky and her horse! They are waiting for you on Threads, Facebook, Instagram and X. Handle: @secretroompod. YOUTUBE The Secret Room is now on YouTube! THE SECRET ROOM | UNLOCKED Siobahn lives a picture perfect, white picket-fence life … she's married with three kids, and has all the things you're supposed to want. But underneath she's kept a secret: a longing for something out of reach. Siobahn's always been attracted to women, and has never taken the chance to fully explore her true self. Host: Susie Lark. The Secret Room | Unlocked is yours when you support your favorite indie podcast that could with a membership at patreon.com/secretroom, Apple Podcasts or Spotify. There's a free trial! ALL OUR SPONSORS See all our sponsors past and present, and their offers, many of which are still valid: secretroompodcast.com/codes FACEBOOK DISCUSSION GROUPThere's even more fun at The Secret Room Podcast Facebook Discussion Page! Just ask to join, all are welcome. :) YOUR SECRET Click "Share a Secret" at secretroompod.com! PODCAST TEAM Producer: Susie Lark. Story Development: Luna Patel. Music and Theme: Breakmaster Cylinder. LISTENER SURVEY Take our Listener Survey at SecretRoomPod.com!
ShadyPanda plays the long game. India mandates tracking software on mobile devices. Korea weighs punitive damages after a massive breach. Qualcomm patches a critical boot flaw impacting millions. OpenAI patches a Codex CLI vulnerability. Google patches Android zero-days. Cybersecurity issues prompt an FDA permanent recall for an at-home ventilator system. Switzerland questions the security of hyperscale clouds and SaaS services. One of the world's largest cyber insurers pulls back from the market. On our Threat Vector segment, David Moulton sits down with Stav Setty to unpack the Jingle Thief campaign. In Russia, Porsches take a holiday. Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. Threat Vector segment In today's Threat Vector segment, host David Moulton, Senior Director of Thought Leadership for Unit 42, sits down with Stav Setty, Principal Researcher at Palo Alto Networks, to unpack Jingle Thief a cloud-only, identity-driven campaign that turned Microsoft 365 into a gift card printing press. Stav explains how the Morocco-based group known as Atlas Lion lived off the land inside M365 for months at a time, using tailored phishing and smishing pages, URL tricks, and internal phishing to compromise one user and quietly pivot to dozens more. To listen to the full conversation on Threat Vector, listen here. You can catch new episodes of Threat Vector every Thursday on your favorite podcast app. Selected Reading Browser extensions pushed malware to 4.3M Chrome, Edge users (The Register) India plans to verify and record every smartphone in circulation (TechCrunch) Apple to Resist India's Order to Preload Government App on iPhones (MacRumors) President orders probe into Coupang breach (The Korea Herald) Qualcomm Alerts Users to Critical Flaws That Compromise the Secure Boot Process (GB Hackers) Vulnerability in OpenAI Coding Agent Could Facilitate Attacks on Developers (SecurityWeek) Google Releases Patches for Android Zero-Day Flaws Exploited in the Wild (Infosecurity Magazine) 'Cyber Issue' Leads to FDA Recall of Baxter Respiratory Gear (GovInfoSecurity) Swiss government bans SaaS and cloud for sensitive info (The Register) Publication: Resolution on outsourcing data processing to the cloud (Privatim) Insurer Beazley Steps Back From Cyber Market as Attacks Surge (PYMNTS.com) Hundreds of Porsche Owners in Russia Unable to Start Cars After System Failure (The Moscow Times) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices
White House says continued mass migration from the Third World is literally unsustainable, Trump doubles down on calling Tim Walz "retarded," the surviving D.C. Guardsman shows signs of recovery, Mark Kelly still won't disavow sedition, Keith Ellison caught on tape cozying up to future Feeding Our Future fraud defendants, home sellers slashing prices by record amounts, FDA quietly admits COVID shots killed kids, Joe Rogan says "Christianity works," Alex Jones preaches repentance, and a warning that college football is on the fast track to a Cloward-Piven collapse. The AM Update, Aaron McIntire, Trump immigration, reverse migration, Tim Walz, Afghan attack, National Guard, Mark Kelly sedition, Keith Ellison scandal, housing market, COVID vaccine deaths, Joe Rogan Christian, Alex Jones repent, college football collapse